Origin of the Normal and Inverse Hysteresis Behavior during CO Oxidation over Pt/Al2O3
January 4, 2017Origin of the Normal and Inverse Hysteresis Behavior during CO Oxidation over Pt/Al2O3
1 min read
ACS Catalysis, Prof. Dr. Jan-Dierk Grunwaldt, KIT Karlsruhe.Origin of the Normal and Inverse Hysteresis Behavior during CO Oxidation over Pt/Al2O3
By the application of conventional and advanced preparation methods, such as flame spray pyrolysis and supercritical fluid reactive deposition, a series of catalysts containing homogeneous distributions of Pt particles were obtained. An optimal Pt particle size of 2−3 nm was identified for the CO oxidation light-off on Pt/Al2O3 catalysts. The CO oxidation results show a clear correlation between the Pt nanoparticle size and the ignition/extinction profile, including the switch of the hysteresis loop.
For details:
Origin of the Normal and Inverse Hysteresis Behavior during CO Oxidation over Pt/Al2O3Maria Casapu,*,† Anna Fischer,† Andreas M. Gänzler,† Radian Popescu,‡ Marlene Crone,§ Dagmar Gerthsen,‡ Michael Türk,§ and Jan-Dierk Grunwaldt*,†
†Institute for Chemical Technology and Polymer Chemistry, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
‡Laboratory for Electron Microscopy, Karlsruhe Institute of Technology (KIT), 76128 Karlsruhe, Germany
§Institute for Technical Thermodynamics and Refrigeration, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
ACS Catalysis – November 2016
DOI: 10.1021/acscatal.6b02709
Enjoy this article? Why not share it with your network?
The systematic, autonomous optimization of discrete reaction parameters in organic synthesis remains unexplored, offering the potential to revolutionize synthetic methodology and expand the scope and efficiency of reaction development.
Autonomous laboratories can accelerate discoveries in chemical synthesis, but this requires automated measurements coupled with reliable decision-making.
The integration of artificial intelligence (AI) and machine learning (ML) in drug design has the potential to transform small molecule drug discovery in the pharmaceutical industry, enhancing the efficiency and productivity of the drug design and discovery process.